Press release
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Analysis, Top Segments, Market Research Report: 2024-2033
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
According to The Business Research Company's, The ribose-nucleic acid (RNA)-based therapeutics market size has grown strongly in recent years. It will grow from $14.54 billion in 2023 to $15.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships.
The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $22.30 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report
Market Drivers and Trends:
The increasing prevalence of cancer is expected to propel the growth of the ribose-nucleic acid (RNA)-based therapeutics market going forward. Cancer refers to a condition where abnormal cells grow and spread uncontrollably, potentially leading to death if untreated. The prevalence of cancer is due to an aging population, lifestyle changes, greater exposure to risks, and better detection methods. RNA-based therapeutics offer a promising avenue for cancer treatment by directly targeting the genetic and molecular mechanisms of cancer. For instance, in August 2023, according to the Australian Institute of Health and Welfare, an Australia-based government administration for health, around 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, which is expected to reach 185,000 in 2030. Therefore, the increasing prevalence of cancer is driving the ribose-nucleic acid (RNA)-based therapeutics market.
Major companies operating in the ribose nucleic acid (RNA)-based therapeutics market are focused on developing innovative medication solutions, such as messenger RNA (mRNA)-based booster vaccines, to enhance the effectiveness of immunization, address emerging viral variants, and improve the overall durability of vaccine-induced immunity. An mRNA-based booster vaccine uses messenger RNA to prompt cells to create a protein that enhances the body's immune response against a particular pathogen. For instance, in June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, launched GEMCOVAC-OM, a India's first mRNA booster vaccine specifically targeting the Omicron variant of COVID-19. This booster is essential due to the limited efficacy of the original vaccines against Omicron. Utilizing mRNA technology, GEMCOVAC-OM boosts immunity and offers enhanced protection against the evolving virus.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2024 Key Insights:
• The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $22.30 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%.
• Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market
• Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines
• North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
"""Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Analysis, Top Segments, Market Research Report: 2024-2033 here
News-ID: 3721231 • Views: …
More Releases from The Business research company
Rail Transit Protective Coating Market Overview: Major Segments, Strategic Devel …
The rail transit protective coating sector is positioned for significant expansion in the coming years, driven by technological advancements and increasing infrastructure investments. This market is evolving rapidly as stakeholders prioritize durability, sustainability, and efficiency in rail transit systems. Let's explore the market's valuation projections, leading companies, emerging trends, and detailed segment analysis to get a clearer understanding of its future trajectory.
Expected Market Size and Growth Outlook for Rail Transit…
Analysis of Segments and Major Growth Areas in the Product Implementation Servic …
The product implementation services sector is on the verge of significant expansion, driven by evolving technology needs and increasing enterprise adoption of sophisticated systems. Understanding the current market size, key contributors, emerging trends, and segment breakdowns offers valuable insights into what lies ahead for this dynamic industry.
Market Size and Expected Growth Trajectory in the Product Implementation Services Market
The product implementation services market is projected to experience strong growth…
Key Strategic Developments and Emerging Changes Shaping the Polyvinylidene Fluor …
The polyvinylidene fluoride (PVDF) resin market is on track for significant expansion over the coming years. Driven by various technological advances and rising demands across multiple industries, this sector is expected to evolve rapidly. Let's explore the anticipated market growth, influential players, key trends, and detailed segmentation shaping the future of PVDF resin.
Projected Growth and Market Size of the Polyvinylidene Fluoride Resin Market
The PVDF resin market is forecasted…
Leading Companies Fueling Innovation and Growth in the Partyline Intercom System …
The partyline intercom systems market is gearing up for significant expansion as communication needs evolve across various industries. With increasing demand for more versatile and efficient communication tools, this sector is set to witness rapid advancements and growing adoption over the coming years. Let's explore the market size projections, key drivers, major players, emerging trends, and important segments shaping this dynamic industry.
Projected Market Size and Growth Trajectory of the Partyline…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
